HM.BioConsulting
Fractional Business Development, Marketing & Commercialization
Empowering Emerging Companies in Biotech & Med Tech
.jpg)
Henning Mann, PhD
“The advantage of fractional services isn’t cost savings, it’s precision: the right expertise, at the right moment, without the weight of a full organization.
You shouldn’t have to hire a full team to move forward. Just the right people, at the right time.”
At HM.BioConsulting, we partner with biotech and medtech companies to accelerate growth through focused business development, marketing, and commercialization strategy.
Founded by Henning Mann, a startup veteran with deep academic and industry experience, HMBC operates as a consortium of senior experts delivering practical, execution-driven support.
We help translate scientific innovation into clear positioning, strong partnerships, and commercial traction.
Our approach is targeted, flexible, and built around your specific stage and challenges, so you can stay focused on advancing your science while we drive the path to market.
Our Approach
Our model is built around precision, bringing you the right expertise, exactly when you need it.
Engage HMBC across targeted areas such as business development, marketing, visual communications and design, partnerships, and commercialization planning - or deploy a broader, integrated approach as your needs evolve.
We operate as a flexible extension of your team, combining senior-level insight with execution across marketing, strategy, and commercial operations, without the burden of building it all in-house.
Scale support up or down as needed and focus your resources where they matter most.
